Our mission is to deliver high quality multidisciplinary research designed to improve the content, delivery and configuration of primary care for the benefit of patients with musculoskeletal conditions, mental health problems and comorbidities.


iPCHS' STarT Back tool recognised in UK's 'Best Breakthroughs' list

Posted on 06 December 2018 iPCHs researchers have transformed back pain treatment, improving the lives of millions of people around the world with our 'STarT Back' tool. The innovative treatment has today been named as one of the UK's 100 'Best Breakthroughs' for its significant impact on people's everyday lives.

International success for PD-CRAFT study

Posted on 30 November 2018 A study led by researchers at Keele’s Treatment Institute for Primary Care and Health Sciences and Clinical Trials Unit have achieved international success by becoming the largest source of recruitment to the international biological determinants of peritoneal dialysis study, and have exceeded their patient recruitment target ahead of time.

iPCHS awarded funding to help people with health conditions stay in work

Posted on 29 November 2018 iPCHS researchers have been awarded £200,000 from the Goverment's new Work and Health Challenge Fund, to help support people with musculoskeletal conditions to stay in work.

Popular drug combination for drug treatment resistant depressions in not more effective than a single antidepressant in primary care

Posted on 26 October 2018 A large clinical trial led by researchers at the universities of Keele, Bristol, Exeter, Manchester and Hull looked at the effectiveness of adding mirtazepine to an SSRI and SNRI in patients who remain depressed after six weeks of conventional antidepressant treatment. They found this combination was no more effective in improving depression than placebo, and call on doctors to rethink its use.